Company / Cost of Revenue
Orthofix Medical Inc. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$260.4M
FY2025
5-year range
$100.6M / $260.4M
FY2021-FY2025
Trend
+110.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 8 consecutive years, from $87M in FY2017 to $260M in FY2025.
Based on SEC 10-K filings.
$260M in FY2025 with a 5-year CAGR of +21.9%.
Increased from $115M to $260M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- +21.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Orthofix Medical Inc.'s cost of revenue has grown for 8 consecutive years.
- 5-year CAGR of +21.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 110.7% year-over-year.
- Lowest cost of revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $260.4M | +110.7% |
| FY2024 | $123.5M | +7.5% |
| FY2023 | $114.9M | +12.8% |
| FY2022 | $101.9M | +1.3% |
| FY2021 | $100.6M | +4.1% |
| FY2020 | $96.6M | +3.9% |
| FY2019 | $93.0M | +5.9% |
| FY2018 | $87.9M | +1.5% |
| FY2017 | $86.5M | -12.5% |
| FY2016 | $98.9M | -7.5% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026